BRIEF-Clarus Therapeutics Holdings Inc Files Non-Timely 10-Q With U.S. SEC

Reuters2022-08-16

Aug 16 (Reuters) - Clarus Therapeutics Holdings Inc

* CLARUS THERAPEUTICS HOLDINGS INC FILES NON-TIMELY 10-Q WITH U.S. SEC

* CLARUS THERAPEUTICS HOLDINGS-AS RESULT OF WORKFORCE REDUCTION THAT BEING IMPLEMENTED, CO REQUIRES ADDITIONAL TIME TO COMPLETE PREPARATION OF FORM 10-Q

* CLARUS THERAPEUTICS HOLDINGS SAYS EXPECTS TO FILE Q2 FORM 10-Q ON OR BEFORE FIFTH CALENDAR DAY EXTENSION PROVIDED UNDER RULE 12B-25

Source text for Eikon: [ID: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2259882692?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-08-16 18:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2259882692","market":"us","top_or_hot":-1,"title":"BRIEF-Clarus Therapeutics Holdings Inc Files Non-Timely 10-Q With U.S. SEC","media":"Reuters","content":"<html><body><p>Aug 16 (Reuters) - Clarus Therapeutics Holdings Inc</p><p> :</p><p>   * CLARUS THERAPEUTICS HOLDINGS INC FILES NON-TIMELY 10-Q WITH U.S. SEC</p><p>   * CLARUS THERAPEUTICS HOLDINGS-AS RESULT OF WORKFORCE REDUCTION THAT BEING IMPLEMENTED, CO REQUIRES ADDITIONAL TIME TO COMPLETE PREPARATION OF FORM 10-Q</p><p>   * CLARUS THERAPEUTICS HOLDINGS SAYS EXPECTS TO FILE Q2 FORM 10-Q ON OR BEFORE FIFTH CALENDAR DAY EXTENSION PROVIDED UNDER RULE 12B-25</p><p>Source text for Eikon: [ID:  Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Clarus Therapeutics Holdings Inc Files Non-Timely 10-Q With U.S. SEC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Clarus Therapeutics Holdings Inc Files Non-Timely 10-Q With U.S. SEC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-16 18:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Aug 16 (Reuters) - Clarus Therapeutics Holdings Inc :   * CLARUS THERAPEUTICS HOLDINGS INC FILES NON-TIMELY 10-Q WITH U.S. SEC   * CLARUS THERAPEUTICS HOLDINGS-AS RESULT OF WORKFORCE REDUCTION THAT ...</p>\n\n<a href=\"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LHDX","symbol_name":"Lucira Health, Inc.","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2259882692","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2259882692","pubTimestamp":1660646743,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Aug 16 (Reuters) - Clarus Therapeutics Holdings Inc :   * CLARUS THERAPEUTICS HOLDINGS INC FILES NON","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LHDX":"Lucira Health, Inc.","CRXT":"Clarus Therapeutics Holdings, Inc.","BK4139":"生物科技","SANA":"Sana Biotechnology, Inc.","ONTF":"ON24, Inc.","APR":"Apria, Inc.","BK4007":"制药","BK4023":"应用软件","CGEM":"Cullinan Therapeutics","BK4196":"保健护理服务","LABP":"Landos Biopharma, Inc.","BK4082":"医疗保健设备"},"translate_title":"简讯-Clarus Therapeutics Holdings Inc.向美国证券交易委员会提交非及时10-Q文件","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APR":1,"CGEM":1,"LABP":1,"LHDX":1,"ONTF":1,"SANA":1,"CRXT":0.9},"content_text":"Aug 16 (Reuters) - Clarus Therapeutics Holdings Inc :   * CLARUS THERAPEUTICS HOLDINGS INC FILES NON-TIMELY 10-Q WITH U.S. SEC   * CLARUS THERAPEUTICS HOLDINGS-AS RESULT OF WORKFORCE REDUCTION THAT BEING IMPLEMENTED, CO REQUIRES ADDITIONAL TIME TO COMPLETE PREPARATION OF FORM 10-Q   * CLARUS THERAPEUTICS HOLDINGS SAYS EXPECTS TO FILE Q2 FORM 10-Q ON OR BEFORE FIFTH CALENDAR DAY EXTENSION PROVIDED UNDER RULE 12B-25Source text for Eikon: [ID:  Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2259882692"}